NovoCure Cash from Financing (TTM) Trends

NovoCure Ltd (NVCR)

12.22 -0.12 (-0.93%) USD | NASDAQ | Apr 25, 16:00

12.22 0.00 (0.00%) After-Hours: 16:30

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	15.79M
September 30, 2023	17.29M
June 30, 2023	20.32M
March 31, 2023	17.55M
December 31, 2022	15.49M
September 30, 2022	15.73M
June 30, 2022	14.56M
March 31, 2022	20.89M
December 31, 2021	25.70M
September 30, 2021	592.90M
June 30, 2021	449.38M
March 31, 2021	443.66M
December 31, 2020	440.21M
September 30, 2020	-122.06M
June 30, 2020	33.90M
March 31, 2020	49.21M
December 31, 2019	61.68M

Date	Value
September 30, 2019	55.66M
June 30, 2019	44.09M
March 31, 2019	34.62M
December 31, 2018	69.37M
September 30, 2018	68.13M
June 30, 2018	65.94M
March 31, 2018	56.82M
December 31, 2017	5.168M
September 30, 2017	5.167M
June 30, 2017	76.31M
March 31, 2017	75.14M
December 31, 2016	75.12M
September 30, 2016	235.05M
June 30, 2016	160.76M
March 31, 2016	253.24M
December 31, 2015	276.99M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-122.06M

Minimum

Sep 2020

592.90M

Maximum

Sep 2021

116.42M

Average

25.70M

Median

Dec 2021

Cash from Financing (TTM) Benchmarks